STEVEN M PAUL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for STEVEN M PAUL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of STEVEN M PAUL. STEVEN M PAUL is a Director in SIGMA ALDRICH CORP ($SIAL) and a Director in ALNYLAM PHARMACEUTICALS, INC. ($ALNY) and a in Sage Therapeutics, Inc. ($SAGE) and a Director in Sage Therapeutics, Inc. ($SAGE) and an Chief Executive Officer in Voyager Therapeutics, Inc. ($VYGR) and a Director in Voyager Therapeutics, Inc. ($VYGR) and a President and CEO in Voyager Therapeutics, Inc. ($VYGR) and a President & CEO in Karuna Therapeutics, Inc. ($KRTX) and a PRESIDENT & CEO in Karuna Therapeutics, Inc. ($KRTX).
Companies in which STEVEN M PAUL is an Insider
ALNYLAM PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEVEN M PAUL: Director
Holdings: 16,000 shares
Current Value: $647,360
Latest Transaction: Dec 22 2020
$ALNY Market Capitalization: $3.49B
$ALNY Previous Close: $40.46
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Karuna Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEVEN M PAUL: PRESIDENT & CEO, President & CEO
Holdings: 398,692 shares
Latest Transaction: Feb 24 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sage Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEVEN M PAUL:
Holdings: 127,286 shares
Current Value: $6,071,542
Latest Transaction: Jun 11 2020
$SAGE Market Capitalization: $1.75B
$SAGE Previous Close: $47.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SIGMA ALDRICH CORP
Industry: WHOLESALE-CHEMICALS & ALLIED PRODUCTS [5160]
Position of STEVEN M PAUL: Director
Holdings: 0 shares
Latest Transaction: Nov 19 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Voyager Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of STEVEN M PAUL: Director, Chief Executive Officer, President and CEO
Holdings: 872,351 shares
Current Value: $10,258,848
Latest Transaction: Jun 05 2020
$VYGR Market Capitalization: $316.10M
$VYGR Previous Close: $11.76
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of STEVEN M PAUL
Sentiment: All, ALNY, KRTX, SAGE, SIAL, VYGR
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 24 2021 | KRTX | Karuna Therapeutic ... | PAUL STEVEN M | President & CEO | Option Exercise | A | 131.64 | 161,850 | 21,305,934 | 161,850 | |
| Dec 22 2020 | ALNY | ALNYLAM PHARMACEUT ... | PAUL STEVEN M | Director | Option Exercise | M | 9.30 | 15,000 | 139,500 | 0 | |
| Dec 22 2020 | ALNY | ALNYLAM PHARMACEUT ... | PAUL STEVEN M | Director | Sell | S | 140.00 | 15,000 | 2,100,000 | 1,000 | 16 K to 1,000 (-93.75 %) |
| Dec 22 2020 | ALNY | ALNYLAM PHARMACEUT ... | PAUL STEVEN M | Director | Buy | M | 9.30 | 15,000 | 139,500 | 16,000 | 1,000 to 16 K (+1,500.00 %) |
| Jul 06 2020 | ALNY | ALNYLAM PHARMACEUT ... | PAUL STEVEN M | Director | Option Exercise | A | 148.77 | 4,581 | 681,515 | 4,581 | |
| Jul 06 2020 | ALNY | ALNYLAM PHARMACEUT ... | PAUL STEVEN M | Director | Option Exercise | A | 148.77 | 4,581 | 681,515 | 4,581 | |
| Jun 30 2020 | KRTX | Karuna Therapeutic ... | PAUL STEVEN M | PRESIDENT & CEO | Option Exercise | M | 0.11 | 292,207 | 32,143 | 0 |